Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor

Molecular Pharmacology

Volumn 63, Issue 3, 2003, Pages 699-705

  Offertáler, László ^a   Mo, Fong Ming ^e   Bátkai, Sándor ^a   Liu, Jie ^a   Begg, Malcolm ^a   Razdan, Raj K ^b   Martin, Billy R ^c   Bukoski, Richard D ^d   Kunos, George ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b ORGANIX INC   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^e MSC 8115 ^*

Author keywords

[No Author keywords available]

Indexed keywords

11 HYDROXY DELTA9 TETRAHYDROCANNABINOL DIMETHYLHEPTYL ESTER; 4 [3 (4 MENTHADIEN[1,8]YL)]OLIVETOL; ANANDAMIDE; ANANDAMIDE RECEPTOR; CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL; CANNABIDIOL DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CAPSAZEPINE; CHARYBDOTOXIN; DEXANABINOL; DRUG RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; O 1918; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR; VANILLOID VR1 RECEPTOR ANTAGONIST; VASODILATOR AGENT;

ANIMAL CELL; ARTERY DILATATION; ARTICLE; CANNABIS ADDICTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; ENZYME BINDING; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HYPOTENSION; INHIBITION KINETICS; LIGAND BINDING; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASODILATATION;

ANIMALS; CANNABIDIOL; ENDOTHELIUM, VASCULAR; GTP-BINDING PROTEINS; HUMANS; LIGANDS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VASODILATION;

EID: 0242584643     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.63.3.699     Document Type: Article

References (41)

1. Adams MD, Earnhardt JT, Martin BR, Harris LS, Dewey WL, and Razdan RK (1977) A cannabinoid with cardiovascular activity but no overt behavioral effects. Experientia 33:1204-1205.
2. 2 receptor binding. Drug Alcohol Depend 60:133-140.
3. Breivogel CS, Griffin G, Di Marzo V, and Martin BR (2001) Evidence for a new G protein-coupled receptor in mouse brain. Mol Pharmacol 60:155-163.
4. 1 receptor-deficient mice. Hypertension 39:251-257.
5. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science (Wash DC) 296:1655-1657.
6. Chaytor AT, Martin PEM, Evans WH, Randall MD, and Griffith TM (1999) The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication. J Physiol (Lond) 520:539-550.
7. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature (Lond) 396:269-272.
8. Ellis EF, Moore SF, and Willoughby KA (1995) Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am J Physiol 269:H1859-H1864.
9. Ford WR, Honan SA, White R, and Hiley CR (2002) Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilator responses in rat isolated hearts. Br J Pharmacol 135:1191-1198.
10. Garcia ML, Knaus, H-G, Munujos P, Slaughter RS, and Kaczorowski GJ (1995) Charybdotoxin and its effects on potassium channels. Am J Physiol 269:C1-C10.
11. 2+ channel current. Am J Physiol 276:H2085-H2093.
12. Grainger J and Boachie-Ansah G (2001) Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134:1003-1012.
13. Hajos N, Ledent C, and Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1-4.
14. Harris D, McCulloch AI, Kendall DA, and Randall MD (2002) Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J Physiol (Lond) 539:893-902.
15. Hill CE, Phillips JK, and Sandow SL (2001) Heterogeneous control of blood flow amongst different vascular beds. Med Res Rev 21:1-60.
16. Hillard CJ (2000) Endocannabinoids and cardiovascular function. J Pharmacol Exp Ther 294:27-32.
17. Ishac EJN, Jiang L, Lake KD, Varga K, Abood ME, and Kunos G (1996) Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-2028.
18. 2+-induced relaxation of isolated mesenteric resistance arteries. J Pharmacol Exp Ther 289:245-250.
19. 2 receptors. Proc Natl Acad Sci USA 96:14136-14141.
20. Kunos G, Jarai Z, Varga K, Liu J, Wang L, and Wagner JA (2000) Cardiovascular effects of endocannabinoids - the plot thickens. Prostaglandins Other Lipid Mediat 61:71-84.
21. Lake KD, Compton DR, Varga K, Martin BR, and Kunos G (1997) Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281:1030-1037.
22. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (Wash DC) 283:401-404.
23. Liu J, Gao B, Mirshahi F, Sanyal AJ, Khanolkar AD, Makriyannis A, and Kunos G (2000) Functional CB1 cannabinoid receptors in human vascular endothelial cells. Biochem J 346:835-840.
24. Liu J, Tian Z, Gao B, and Kunos G (2002) Dose-dependent activation ofantiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells. J Biol Chem 277:20927-20933.
25. Mechoulam R, Fride E, and Di Marzo V (1998) Endocannabinoids. Eur J Pharmacol 359:1-18.
26. Mukhopadhyay S, Chapnick BM, and Howlett AC (2002) Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol 282:H2046-H2054.
27. Pratt PF, Hillard CJ, Edgemond WS, and Campbell WB (1998) N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol 43:H375-H381.
28. Randall MD, Harris D, Kendall DA, and Ralevic V (2002) Cardiovascular effects of cannabinoids. Pharmacol Ther 95:191-202.
29. Randall MD and Kendall DA (1997) Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 335:205-209.
30. Razdan RK, Dalzell HC, and Handrick GR (1974) Hashish. A simple one-step synthesis of (-)-delta1-tetrahydrocannabinol (THC) from p-mentha-2, 8-dien-1-ol and olivetol. J Am Chem Soc 96:5860-5865.
31. Showalter V, Compton DR, Martin BR, and Abood ME (1996) Evaluation of binding in transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-999.
32. Varga K, Lake K, Huangfu D, Guyenet PG, and Kunos G (1996) Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28:682-686.
33. Varga K, Lake K, Martin BR, and Kunos G (1995) Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279-283.
34. Varga K, Wagner JA, Bridgen DT, and Kunos G (1998) Platelet- and macrophage-derived cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12:1035-1044.
35. 9-trans-tetrahydrocannabinol. J Pharm Pharmacol 26:186-192.
36. 1 receptors. Eur J Pharmacol 423:203-210.
37. Wagner JA, Varga K, Jarai Z, and Kunos G (1999) Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33:4529-434.
38. White R and Hiley CR (1997) A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol 122:1573-1584.
39. White R, Venessa Ho W, Bottrill FE, Ford WR, and Hiley CR (2001) Mechanism of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol 134:921-929.
40. 9-Tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism. J Neurosci 22:4720-4727.
41. Zygmunt PM, Petersson J, Andersson DA, Chuang HH, Sorgard M, Di Marzo V, Julius D, and Hogestatt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (Lond) 400:452-457.